Some factors such as insulin resistance and inhibition of the IGF-1/Akt protein synthesis pathway are also necessary for CKD-induced muscle atrophy, which provides a potential scientific target for the development of new drugs for muscle atrophy caused by CKD. Here, AKT1 is linked to chronic kidney disease.